Thyrocare Technologies informs about disclosure

05 May 2022 Evaluate
Thyrocare Technologies  has informed about appointment of Rahul Guha as Managing Director and Chief Executive Officer of the company with effective from 04-May-2022. Rahul Guha will also function as the Managing Director & CEO of Nueclear Healthcare, its wholly owned subsidiary. Dharmil Sheth, who was appointed as the Managing Director for the interim period to comply with the provisions of Sec. 203 (4) of the Companies Act, 2013, has demitted office effective from Wednesday, May 04, 2022 and will continue to be a Non-Executive, Non-Independent Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

363.10 -6.35 (-1.72%)
12-Mar-2026 09:21 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7596.00
Max Healthcare Inst 1022.50
Narayana Hrudayalay 1702.00
Aster DM Healthcare 680.55
Global Health 1068.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×